Journal of Biological Chemistry · 1996 · 214 citations · 32 references
Life SciencesImmunologyMicrobiologyBacteriologyInnate ImmunityMedical MicrobiologyAntimicrobial PeptidesBacterial ImmunologyCell-surface ReceptorsHost Cell AttachmentInnate Immune ReceptorsPathogen RecognitionBacterial Peptidoglycan SensingHost-pathogen Glycan RecognitionMicrobial Glycan SignalingPeptidoglycan Cell WallPeptidoglycan Recognition Proteins
The hypothesis that CD14 (an endotoxin receptor present on macrophages and neutrophils) acts as a cell-activating receptor for bacterial peptidoglycan was tested using mouse 70Z/3 cells transfected with human CD14. 70Z/3 cells transfected with an empty vector were unresponsive to insoluble and soluble peptidoglycan, as well as to low concentrations of endotoxin. 70Z/3-CD14 cells were responsive to both insoluble and soluble peptidoglycan, as well as to low concentrations of endotoxin, as measured by the expression of surface IgM, activation of NF-κB, and degradation of IκB-α. Peptidoglycan also induced activation of NF-κB and degradation of IκB-α in macrophage RAW264.7 cells. These peptidoglycan-induced effects (in contrast to endotoxin-induced effects) were not inhibited by polymyxin B. Both peptidoglycan- and endotoxin-induced activation of NF-κB were inhibited by anti-CD14 mAb. The N-terminal 151 amino acids of CD14 were sufficient for acquisition of full responsiveness to both peptidoglycan and endotoxin, but CD14 deletion mutants lacking four small regions within the N-terminal 65 amino acids showed differentially diminished responses to peptidoglycan and endotoxin. These results identify CD14 as the functional receptor for peptidoglycan and demonstrate that similar, but not identical sequences in the N-terminal 65-amino acid region of CD14 are critical for the NF-κB and IgM responses to both peptidoglycan and endotoxin. The hypothesis that CD14 (an endotoxin receptor present on macrophages and neutrophils) acts as a cell-activating receptor for bacterial peptidoglycan was tested using mouse 70Z/3 cells transfected with human CD14. 70Z/3 cells transfected with an empty vector were unresponsive to insoluble and soluble peptidoglycan, as well as to low concentrations of endotoxin. 70Z/3-CD14 cells were responsive to both insoluble and soluble peptidoglycan, as well as to low concentrations of endotoxin, as measured by the expression of surface IgM, activation of NF-κB, and degradation of IκB-α. Peptidoglycan also induced activation of NF-κB and degradation of IκB-α in macrophage RAW264.7 cells. These peptidoglycan-induced effects (in contrast to endotoxin-induced effects) were not inhibited by polymyxin B. Both peptidoglycan- and endotoxin-induced activation of NF-κB were inhibited by anti-CD14 mAb. The N-terminal 151 amino acids of CD14 were sufficient for acquisition of full responsiveness to both peptidoglycan and endotoxin, but CD14 deletion mutants lacking four small regions within the N-terminal 65 amino acids showed differentially diminished responses to peptidoglycan and endotoxin. These results identify CD14 as the functional receptor for peptidoglycan and demonstrate that similar, but not identical sequences in the N-terminal 65-amino acid region of CD14 are critical for the NF-κB and IgM responses to both peptidoglycan and endotoxin. INTRODUCTIONPeptidoglycan (PGN) 1The abbreviations used are: PGNpeptidoglycanDAFdecay-accelerating factorGPIglycosylphosphatidylinositolLAMlipoarabinomannanLPSlipopolysaccharideNF-κBnuclear factor κBReLPSLPS from S. minnesota Re 595sIgMsurface IgMsPGNsoluble PGNRSVRous sarcoma virusmAbmonoclonal antibody. is a polymer of alternating GlcNAc and MurNAc cross-linked by short peptides, present in the cell walls of all bacteria. PGN is especially abundant in Gram-positive bacteria, in which it accounts for half of the mass of their cell wall (1Schleifer K.H. Kandler O. Bacteriol. Rev. 1972; 36: 407-477Crossref PubMed Google Scholar). Host cells are exposed to large amounts of insoluble PGN in the form of cell wall debris that are deposited at the sites of infection (2Heymer B. Seidl P.H. Schleifer K.H. Stewart-Tull D.E.S. Davies M. Immunology of the Bacterial Cell Envelope. John Wiley & Sons, New York1985: 11Google Scholar), and also to polymeric uncross-linked soluble PGN (sPGN) fragments that are released from bacteria in the presence of β-lactam antibiotics (3Mirelman D. Bracha R. Sharon N. Biochemistry. 1974; 13: 5045-5053Crossref PubMed Scopus (30) Google Scholar, 4Zeiger A.R. Wong W. Chatterjee A.N. Young F.E. Tuazon C.U. Infect. Immun. 1982; 37: 1112-1118Crossref PubMed Google Scholar).PGN, similarly to lipopolysaccharide (LPS) from the cell walls of Gram-negative bacteria, can reproduce most of the clinical manifestations of bacterial infections, including fever, acute-phase response, inflammation, septic shock, leukocytosis, sleepiness, malaise, abscess formation, and arthritis. Most of these effects are due to the release of cytokines and other mediators from macrophages and other cells (2Heymer B. Seidl P.H. Schleifer K.H. Stewart-Tull D.E.S. Davies M. Immunology of the Bacterial Cell Envelope. John Wiley & Sons, New York1985: 11Google Scholar, 5Dziarski R. Seidl H.P. Schleifer K.H. Biological Properties of Peptidoglycan. Walter De Gruyter, Berlin1986: 229-247Crossref Google Scholar, 6Raetz C.R.H. Annu. Rev. Biochem. 1990; 59: 129-170Crossref PubMed Scopus (1030) Google Scholar, 7Rosenthal R.S. Dziarski R. Methods Enzymol. 1994; 235: 253-285Crossref PubMed Scopus (134) Google Scholar, 8Gupta D. Jin Y. Dziarski R. J. Immunol. 1995; 155: 2620-2630PubMed Google Scholar, 9De Kimpe S.J. Kengatharan M. Thiemermann C. Vane J.R. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 10359-10363Crossref PubMed Scopus (295) Google Scholar).It is well established that CD14, a glycosylphosphatidylinositol (GPI)-linked 55-kDa protein present on the surface of macrophages and polymorphonuclear leukocytes, serves as a functional cell surface receptor for LPS (10Wright S.D. Ramos R.A. Tobias P.S. Ulevitch R.J. Mathison J.C. Science. 1990; 249: 1431-1433Crossref PubMed Scopus (3376) Google Scholar, 11Ulevitch R.J. Tobias P.S. Curr. Opin. Immunol. 1994; 6: 125-130Crossref PubMed Scopus (227) Google Scholar, 12Hailman E. Lichenstein H.S. Wurefel M.M. Miller D.S. Johnson D.A. Kelly M. Busse L.A. Zukowski M.M. Wright S.D. J. Exp. Med. 1994; 179: 269-277Crossref PubMed Scopus (612) Google Scholar, 13Viriyakosol S. Kirkland T.N. J. Biol. Chem. 1995; 270: 361-368Abstract Full Text Full Text PDF PubMed Scopus (93) Google Scholar, 14Juan T.S.-C. Kelly M.J. Johnson D.A. Busse L.A. Hailman E. Wright S.D. Lichenstein H.S. J. Biol. Chem. 1995; 270: 1382-1387Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar, 15Gegner J.A. Ulevitch R.J. Tobias P.S. J. Biol. Chem. 1995; 270: 5320-5325Abstract Full Text Full Text PDF PubMed Scopus (237) Google Scholar). The binding of LPS to CD14 is facilitated by the LPS-binding protein present in plasma (10Wright S.D. Ramos R.A. Tobias P.S. Ulevitch R.J. Mathison J.C. Science. 1990; 249: 1431-1433Crossref PubMed Scopus (3376) Google Scholar, 11Ulevitch R.J. Tobias P.S. Curr. Opin. Immunol. 1994; 6: 125-130Crossref PubMed Scopus (227) Google Scholar, 12Hailman E. Lichenstein H.S. Wurefel M.M. Miller D.S. Johnson D.A. Kelly M. Busse L.A. Zukowski M.M. Wright S.D. J. Exp. Med. 1994; 179: 269-277Crossref PubMed Scopus (612) Google Scholar, 13Viriyakosol S. Kirkland T.N. J. Biol. Chem. 1995; 270: 361-368Abstract Full Text Full Text PDF PubMed Scopus (93) Google Scholar, 14Juan T.S.-C. Kelly M.J. Johnson D.A. Busse L.A. Hailman E. Wright S.D. Lichenstein H.S. J. Biol. Chem. 1995; 270: 1382-1387Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar, 15Gegner J.A. Ulevitch R.J. Tobias P.S. J. Biol. Chem. 1995; 270: 5320-5325Abstract Full Text Full Text PDF PubMed Scopus (237) Google Scholar). The cellular receptor for PGN, however, is unknown (16Dziarski R. J. Biol. Chem. 1994; 269: 20431-20436Abstract Full Text PDF PubMed Google Scholar).Because of the similarity of the biologic effects of PGN and LPS (2Heymer B. Seidl P.H. Schleifer K.H. Stewart-Tull D.E.S. Davies M. Immunology of the Bacterial Cell Envelope. John Wiley & Sons, New York1985: 11Google Scholar, 5Dziarski R. Seidl H.P. Schleifer K.H. Biological Properties of Peptidoglycan. Walter De Gruyter, Berlin1986: 229-247Crossref Google Scholar, 6Raetz C.R.H. Annu. Rev. Biochem. 1990; 59: 129-170Crossref PubMed Scopus (1030) Google Scholar, 7Rosenthal R.S. Dziarski R. Methods Enzymol. 1994; 235: 253-285Crossref PubMed Scopus (134) Google Scholar, 8Gupta D. Jin Y. Dziarski R. J. Immunol. 1995; 155: 2620-2630PubMed Google Scholar, 9De Kimpe S.J. Kengatharan M. Thiemermann C. Vane J.R. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 10359-10363Crossref PubMed Scopus (295) Google Scholar), we decided to test the hypothesis that CD14 may serve as a receptor for both LPS and PGN. Our recent results showed that activation of CD14-positive monocytes by PGN (17Weidemann B. Brade H. Reitschel E.T. Dziarski R. Bazil V. Kusumoto S. Flad H.-D. Ulmer A.J. Infect. Immun. 1994; 62: 4709-4715Crossref PubMed Google Scholar) and binding of PGN to CD14-positive monocytes 2B. Weidemann, R. Dziarski, S. Kusumoto, E. T. Reitschel, H. D. Flad, and A. J. Ulmer, submitted for publication. were inhibited by anti-CD14 monoclonal antibodies and LPS partial structures, such as an LPS antagonist, compound 406. These results strongly indicated that CD14 serves as a cell-activating receptor not only for LPS but also for PGN.Here we further test the hypothesis that CD14 is a functional PGN receptor, using mouse 70Z/3 cells stably expressing recombinant human CD14 (70Z/3-hCD14 transfectants). 70Z/3 cells are CD14-negative immature B cells that do not express surface IgM (sIgM) and are unresponsive to PGN and responsive only to high concentrations of LPS. 70Z/3-hCD14 transfectants express GPI-bound hCD14 and become highly responsive to low concentrations of LPS (19Lee J.D. Kato K. Tobias P.S. Kirkland T.N. Ulevitch R.J. J. Exp. Med. 1992; 175: 1697-1705Crossref PubMed Scopus (216) Google Scholar), and the N-terminal 151-amino acid fragment of hCD14 serves as a fully functional LPS receptor (20Viriyakosol S. Kirkland T.N. Infect. Immun. 1996; 64: 653-656Crossref PubMed Google Scholar). Stimulation of these cells results in activation of nuclear factor-κB (NF-κB) and differentiation into more mature B cells that express sIgM (19Lee J.D. Kato K. Tobias P.S. Kirkland T.N. Ulevitch R.J. J. Exp. Med. 1992; 175: 1697-1705Crossref PubMed Scopus (216) Google Scholar, 20Viriyakosol S. Kirkland T.N. Infect. Immun. 1996; 64: 653-656Crossref PubMed Google Scholar). NF-κB is a ubiquitous transcription factor that is sequestered in the cytoplasm bound to its inhibitory protein, IκB (21Baeuerle P.A. Henkel T. Annu. Rev. Immunol. 1994; 12: 141-179Crossref PubMed Scopus (4582) Google Scholar, 22Thanos D. Maniatis T. Cell. 1995; 80: 529-532Abstract Full Text PDF PubMed Scopus (1216) Google Scholar). NF-κB activation involves degradation of IκB in the cytoplasm and translocation of NF-κB into the nucleus (21Baeuerle P.A. Henkel T. Annu. Rev. Immunol. 1994; 12: 141-179Crossref PubMed Scopus (4582) Google Scholar, 22Thanos D. Maniatis T. Cell. 1995; 80: 529-532Abstract Full Text PDF PubMed Scopus (1216) Google Scholar). In this study, we used the above criteria (translocation of NF-κB into the nucleus, degradation of IκB-α in the cytoplasm, and expression of sIgM) to measure activation of 70Z/3-hCD14 cells by PGN and LPS.DISCUSSIONOur results strongly support the hypothesis that CD14 is a functional receptor for both insoluble and soluble staphylococcal PGN, as well as for PGN-containing streptococcal cell walls. They also demonstrate that less than half of membrane CD14 (the N-terminal 151 amino acids) is sufficient for full function of CD14 as a cell-activating PGN receptor, and that the sequences that are most critical for the receptor function of CD14 are located within the N-terminal 65 amino acid region.These results support the hypothesis proposed earlier by us (17Weidemann B. Brade H. Reitschel E.T. Dziarski R. Bazil V. Kusumoto S. Flad H.-D. Ulmer A.J. Infect. Immun. 1994; 62: 4709-4715Crossref PubMed Google Scholar) 3T. N. Kirkland, unpublished observations. and other investigators (31Pugin J. Heumann D. Tomasz A. Kravchenko V.V. Akamatsu Y. Nishijima M. Glauser M.P. Tobias P.S. Ulevitch R.J. Immunity. 1994; 1: 509-516Abstract Full Text PDF PubMed Scopus (622) Google Scholar, 34Wright S.D. J. Immunol. 1995; 155: 6-8PubMed Google Scholar) that CD14 functions not only as an LPS receptor, but also as a receptor for PGN and other bacterial cell wall components. The domain of CD14 that is critical for its function as a receptor for both PGN and LPS is located within the N-terminal 65-amino acid region. The specific amino acid sequences responsible for the function of CD14 as a receptor for both PGN and LPS are similar, but not identical. In agreement with the previous studies (13Viriyakosol S. Kirkland T.N. J. Biol. Chem. 1995; 270: 361-368Abstract Full Text Full Text PDF PubMed Scopus (93) Google Scholar) we confirmed that the AVEVE and PQPD sequences are most crucial for the responsiveness to LPS and that their deletion can almost totally abolish or severely diminish the function of CD14 as an LPS receptor. Single deletions of these sequences only partially diminish the responsiveness to PGN, and deletion of all four studied sequences (DDED, PQPD, DPRQY, and AVEVE) is required to abolish the responsiveness to PGN.The differences between the responses of CD14 mutants to PGN and LPS were consistently observed in several experiments, and they may be due to fine differences in the binding of PGN and LPS to CD14 and/or due to the differences in the requirement for LBP. LBP greatly enhances the responses of CD14-positive cells to low concentrations of LPS (10Wright S.D. Ramos R.A. Tobias P.S. Ulevitch R.J. Mathison J.C. Science. 1990; 249: 1431-1433Crossref PubMed Scopus (3376) Google Scholar, 11Ulevitch R.J. Tobias P.S. Curr. Opin. Immunol. 1994; 6: 125-130Crossref PubMed Scopus (227) Google Scholar, 12Hailman E. Lichenstein H.S. Wurefel M.M. Miller D.S. Johnson D.A. Kelly M. Busse L.A. Zukowski M.M. Wright S.D. J. Exp. Med. 1994; 179: 269-277Crossref PubMed Scopus (612) Google Scholar, 13Viriyakosol S. Kirkland T.N. J. Biol. Chem. 1995; 270: 361-368Abstract Full Text Full Text PDF PubMed Scopus (93) Google Scholar, 14Juan T.S.-C. Kelly M.J. Johnson D.A. Busse L.A. Hailman E. Wright S.D. Lichenstein H.S. J. Biol. Chem. 1995; 270: 1382-1387Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar, 15Gegner J.A. Ulevitch R.J. Tobias P.S. J. Biol. Chem. 1995; 270: 5320-5325Abstract Full Text Full Text PDF PubMed Scopus (237) Google Scholar, 17Weidemann B. Brade H. Reitschel E.T. Dziarski R. Bazil V. Kusumoto S. Flad H.-D. Ulmer A.J. Infect. Immun. 1994; 62: 4709-4715Crossref PubMed Google Scholar, 19Lee J.D. Kato K. Tobias P.S. Kirkland T.N. Ulevitch R.J. J. Exp. Med. 1992; 175: 1697-1705Crossref PubMed Scopus (216) Google Scholar), whereas, LBP does not enhance the responses of human (17Weidemann B. Brade H. Reitschel E.T. Dziarski R. Bazil V. Kusumoto S. Flad H.-D. Ulmer A.J. Infect. Immun. 1994; 62: 4709-4715Crossref PubMed Google Scholar) or rabbit (35Mathison J.C. Tobias P.S. Wolfson E. Ulevitch R.J. J. Immunol. 1992; 149: 200-206PubMed Google Scholar) macrophages or 70Z/3-hCD14 transfectants3 to PGN. These differences may also be due to the post-binding events that are responsible for signal transduction from the receptor and cell activation. The latter notion is supported by our recent discovery that three families of mitogen-activated protein kinases are differentially activated by PGN and LPS in mouse macrophages (36Dziarski R. Jin Y. Gupta D. J. Infect. Dis. 1996; 174 (in press)Crossref PubMed Scopus (101) Google Scholar). PGN strongly activates ERK1 and ERK2, moderately activates JNK, and weakly activates p38 mitogen-activated protein kinases, in contrast to LPS, which strongly activates all of these kinases (36Dziarski R. Jin Y. Gupta D. J. Infect. Dis. 1996; 174 (in press)Crossref PubMed Scopus (101) Google Scholar).The effects of deletion mutations on NF-κB activation (Fig. 9) were usually more severe and clear-cut than the effects on sIgM expression (Fig. 8), e.g. a single ΔPQPD deletion was sufficient to abrogate NF-κB, but not sIgM responses to LPS. These differences most likely reflect the differences in the assay systems and in the requirements for sIgM expression and NF-κB activation, i.e. long stimulation period and likely activation of multiple signal transduction molecules that are required for induction of sIgM. For example, induction of the κ chains in 70Z/3 cells requires activation of at least two transcription factors, NF-κB and OTF-2 (37Rooney J.W. Emery D.W. Sibley C.H. Immunogenetics. 1990; 31: 73-78Crossref PubMed Scopus (19) Google Scholar).The sequences in CD14 that are most critical for the responsiveness to LPS and PGN are hydrophilic and they would be expected to be exposed on the surface of CD14, and thus be available for binding of ligands. These results are consistent with the proposal that LPS binds to the hydrophilic region(s) of CD14 (38Kirikae T. Schade F.U. Zahringer U. Kirikae F. Brade H. Kusama T. Rietchel E.T. FEMS Immun. Med. Microbiol. 1994; 8: 13-26Crossref PubMed Scopus (44) Google Scholar). Comparing the structure of PGN and lipid A (the active part of LPS) (17Weidemann B. Brade H. Reitschel E.T. Dziarski R. Bazil V. Kusumoto S. Flad H.-D. Ulmer A.J. Infect. Immun. 1994; 62: 4709-4715Crossref PubMed Google Scholar) indicates that the only similar parts of the molecules are the (GlcNAc-MurNAc)n backbone of PGN and the (GlcNAc)2 part of lipid A. Because of the hydrophobic nature of the fatty acids in lipid A, in aqueous solutions, lipid A forms aggregates with hydrophilic (GlcNAc)2 exposed on the surface and available for binding to CD14. Therefore, it appears that polysaccharide portions of PGN and lipid A may be involved in binding to CD14.In addition to identifying CD14 as a PGN receptor, our results also demonstrate for the first time that PGN induces activation of transcription factor NF-κB and degradation of IκB-α in both macrophages and in 70Z/3-CD14 transfectants, and expression of surface IgM in 70Z/3-CD14 transfectants. These results extend a previous observation of NF-κB activation in human monocytes by a low molecular weight anhydro monomer derivative of PGN (18Dokter W.H.A. Dijkstra A.J. Koopmans S.B. W. E. J. Biol. Chem. 1994; 269: Full Text PDF PubMed Google Scholar). INTRODUCTIONPeptidoglycan (PGN) 1The abbreviations used are: PGNpeptidoglycanDAFdecay-accelerating factorGPIglycosylphosphatidylinositolLAMlipoarabinomannanLPSlipopolysaccharideNF-κBnuclear factor κBReLPSLPS from S. minnesota Re 595sIgMsurface IgMsPGNsoluble PGNRSVRous sarcoma virusmAbmonoclonal antibody. is a polymer of alternating GlcNAc and MurNAc cross-linked by short peptides, present in the cell walls of all bacteria. PGN is especially abundant in Gram-positive bacteria, in which it accounts for half of the mass of their cell wall (1Schleifer K.H. Kandler O. Bacteriol. Rev. 1972; 36: 407-477Crossref PubMed Google Scholar). Host cells are exposed to large amounts of insoluble PGN in the form of cell wall debris that are deposited at the sites of infection (2Heymer B. Seidl P.H. Schleifer K.H. Stewart-Tull D.E.S. Davies M. Immunology of the Bacterial Cell Envelope. John Wiley & Sons, New York1985: 11Google Scholar), and also to polymeric uncross-linked soluble PGN (sPGN) fragments that are released from bacteria in the presence of β-lactam antibiotics (3Mirelman D. Bracha R. Sharon N. Biochemistry. 1974; 13: 5045-5053Crossref PubMed Scopus (30) Google Scholar, 4Zeiger A.R. Wong W. Chatterjee A.N. Young F.E. Tuazon C.U. Infect. Immun. 1982; 37: 1112-1118Crossref PubMed Google Scholar).PGN, similarly to lipopolysaccharide (LPS) from the cell walls of Gram-negative bacteria, can reproduce most of the clinical manifestations of bacterial infections, including fever, acute-phase response, inflammation, septic shock, leukocytosis, sleepiness, malaise, abscess formation, and arthritis. Most of these effects are due to the release of cytokines and other mediators from macrophages and other cells (2Heymer B. Seidl P.H. Schleifer K.H. Stewart-Tull D.E.S. Davies M. Immunology of the Bacterial Cell Envelope. John Wiley & Sons, New York1985: 11Google Scholar, 5Dziarski R. Seidl H.P. Schleifer K.H. Biological Properties of Peptidoglycan. Walter De Gruyter, Berlin1986: 229-247Crossref Google Scholar, 6Raetz C.R.H. Annu. Rev. Biochem. 1990; 59: 129-170Crossref PubMed Scopus (1030) Google Scholar, 7Rosenthal R.S. Dziarski R. Methods Enzymol. 1994; 235: 253-285Crossref PubMed Scopus (134) Google Scholar, 8Gupta D. Jin Y. Dziarski R. J. Immunol. 1995; 155: 2620-2630PubMed Google Scholar, 9De Kimpe S.J. Kengatharan M. Thiemermann C. Vane J.R. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 10359-10363Crossref PubMed Scopus (295) Google Scholar).It is well established that CD14, a glycosylphosphatidylinositol (GPI)-linked 55-kDa protein present on the surface of macrophages and polymorphonuclear leukocytes, serves as a functional cell surface receptor for LPS (10Wright S.D. Ramos R.A. Tobias P.S. Ulevitch R.J. Mathison J.C. Science. 1990; 249: 1431-1433Crossref PubMed Scopus (3376) Google Scholar, 11Ulevitch R.J. Tobias P.S. Curr. Opin. Immunol. 1994; 6: 125-130Crossref PubMed Scopus (227) Google Scholar, 12Hailman E. Lichenstein H.S. Wurefel M.M. Miller D.S. Johnson D.A. Kelly M. Busse L.A. Zukowski M.M. Wright S.D. J. Exp. Med. 1994; 179: 269-277Crossref PubMed Scopus (612) Google Scholar, 13Viriyakosol S. Kirkland T.N. J. Biol. Chem. 1995; 270: 361-368Abstract Full Text Full Text PDF PubMed Scopus (93) Google Scholar, 14Juan T.S.-C. Kelly M.J. Johnson D.A. Busse L.A. Hailman E. Wright S.D. Lichenstein H.S. J. Biol. Chem. 1995; 270: 1382-1387Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar, 15Gegner J.A. Ulevitch R.J. Tobias P.S. J. Biol. Chem. 1995; 270: 5320-5325Abstract Full Text Full Text PDF PubMed Scopus (237) Google Scholar). The binding of LPS to CD14 is facilitated by the LPS-binding protein present in plasma (10Wright S.D. Ramos R.A. Tobias P.S. Ulevitch R.J. Mathison J.C. Science. 1990; 249: 1431-1433Crossref PubMed Scopus (3376) Google Scholar, 11Ulevitch R.J. Tobias P.S. Curr. Opin. Immunol. 1994; 6: 125-130Crossref PubMed Scopus (227) Google Scholar, 12Hailman E. Lichenstein H.S. Wurefel M.M. Miller D.S. Johnson D.A. Kelly M. Busse L.A. Zukowski M.M. Wright S.D. J. Exp. Med. 1994; 179: 269-277Crossref PubMed Scopus (612) Google Scholar, 13Viriyakosol S. Kirkland T.N. J. Biol. Chem. 1995; 270: 361-368Abstract Full Text Full Text PDF PubMed Scopus (93) Google Scholar, 14Juan T.S.-C. Kelly M.J. Johnson D.A. Busse L.A. Hailman E. Wright S.D. Lichenstein H.S. J. Biol. Chem. 1995; 270: 1382-1387Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar, 15Gegner J.A. Ulevitch R.J. Tobias P.S. J. Biol. Chem. 1995; 270: 5320-5325Abstract Full Text Full Text PDF PubMed Scopus (237) Google Scholar). The cellular receptor for PGN, however, is unknown (16Dziarski R. J. Biol. Chem. 1994; 269: 20431-20436Abstract Full Text PDF PubMed Google Scholar).Because of the similarity of the biologic effects of PGN and LPS (2Heymer B. Seidl P.H. Schleifer K.H. Stewart-Tull D.E.S. Davies M. Immunology of the Bacterial Cell Envelope. John Wiley & Sons, New York1985: 11Google Scholar, 5Dziarski R. Seidl H.P. Schleifer K.H. Biological Properties of Peptidoglycan. Walter De Gruyter, Berlin1986: 229-247Crossref Google Scholar, 6Raetz C.R.H. Annu. Rev. Biochem. 1990; 59: 129-170Crossref PubMed Scopus (1030) Google Scholar, 7Rosenthal R.S. Dziarski R. Methods Enzymol. 1994; 235: 253-285Crossref PubMed Scopus (134) Google Scholar, 8Gupta D. Jin Y. Dziarski R. J. Immunol. 1995; 155: 2620-2630PubMed Google Scholar, 9De Kimpe S.J. Kengatharan M. Thiemermann C. Vane J.R. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 10359-10363Crossref PubMed Scopus (295) Google Scholar), we decided to test the hypothesis that CD14 may serve as a receptor for both LPS and PGN. Our recent results showed that activation of CD14-positive monocytes by PGN (17Weidemann B. Brade H. Reitschel E.T. Dziarski R. Bazil V. Kusumoto S. Flad H.-D. Ulmer A.J. Infect. Immun. 1994; 62: 4709-4715Crossref PubMed Google Scholar) and binding of PGN to CD14-positive monocytes 2B. Weidemann, R. Dziarski, S. Kusumoto, E. T. Reitschel, H. D. Flad, and A. J. Ulmer, submitted for publication. were inhibited by anti-CD14 monoclonal antibodies and LPS partial structures, such as an LPS antagonist, compound 406. These results strongly indicated that CD14 serves as a cell-activating receptor not only for LPS but also for PGN.Here we further test the hypothesis that CD14 is a functional PGN receptor, using mouse 70Z/3 cells stably expressing recombinant human CD14 (70Z/3-hCD14 transfectants). 70Z/3 cells are CD14-negative immature B cells that do not express surface IgM (sIgM) and are unresponsive to PGN and responsive only to high concentrations of LPS. 70Z/3-hCD14 transfectants express GPI-bound hCD14 and become highly responsive to low concentrations of LPS (19Lee J.D. Kato K. Tobias P.S. Kirkland T.N. Ulevitch R.J. J. Exp. Med. 1992; 175: 1697-1705Crossref PubMed Scopus (216) Google Scholar), and the N-terminal 151-amino acid fragment of hCD14 serves as a fully functional LPS receptor (20Viriyakosol S. Kirkland T.N. Infect. Immun. 1996; 64: 653-656Crossref PubMed Google Scholar). Stimulation of these cells results in activation of nuclear factor-κB (NF-κB) and differentiation into more mature B cells that express sIgM (19Lee J.D. Kato K. Tobias P.S. Kirkland T.N. Ulevitch R.J. J. Exp. Med. 1992; 175: 1697-1705Crossref PubMed Scopus (216) Google Scholar, 20Viriyakosol S. Kirkland T.N. Infect. Immun. 1996; 64: 653-656Crossref PubMed Google Scholar). NF-κB is a ubiquitous transcription factor that is sequestered in the cytoplasm bound to its inhibitory protein, IκB (21Baeuerle P.A. Henkel T. Annu. Rev. Immunol. 1994; 12: 141-179Crossref PubMed Scopus (4582) Google Scholar, 22Thanos D. Maniatis T. Cell. 1995; 80: 529-532Abstract Full Text PDF PubMed Scopus (1216) Google Scholar). NF-κB activation involves degradation of IκB in the cytoplasm and translocation of NF-κB into the nucleus (21Baeuerle P.A. Henkel T. Annu. Rev. Immunol. 1994; 12: 141-179Crossref PubMed Scopus (4582) Google Scholar, 22Thanos D. Maniatis T. Cell. 1995; 80: 529-532Abstract Full Text PDF PubMed Scopus (1216) Google Scholar). In this study, we used the above criteria (translocation of NF-κB into the nucleus, degradation of IκB-α in the cytoplasm, and expression of sIgM) to measure activation of 70Z/3-hCD14 cells by PGN and LPS.
32
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Samuel D. Wright, Robert Ramos, Peter S. Tobias et al. · Science · 1990 · 4K citations
Control of IκB-α Proteolysis by Site-Specific, Signal-Induced Phosphorylation
Keith Brown, Susan M. Gerstberger, Louise Carlson et al. · Science · 1995 · 1.4K citations
Alexander N. Shakhov, Martine A. Collart, P Vassalli et al. · The Journal of Experimental Medicine · 1990 · 821 citations · Full text
Management, Organization Studies, Organizational Behavior +15